Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387136019> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- W4387136019 abstract "<h3>Introduction/Background</h3> Because of its asymptomatic progression,ovarian cancer is mainly encountered in advanced stages in women.The standard treatment for ovarian cancer is cytoreductive surgery and chemotherapy with a platinum-taxane combination.Diaphragm peritonectomy,splenectomy,liver resection are among the procedures for the cytoreduction of ovarian cancer that have been reported to be both feasible and associated with acceptable morbidity. This study aims to evaluate the characteristics,treatment process,survival outcomes of patients who underwent aggressive cytoreductive surgery to achieve optimal cytoreduction in ovarian cancer. <h3>Methodology</h3> This study was a retrospective analysis involving patients with epithelial ovarian cancer who underwent cytoreductive surgery by a single gynecologist oncologist between November 2014 and September 2022 in a single center.In the study, aggressive cytoreduction was defined anatomically as debulking of disease proximal to the ligament of Treitz. The patients who underwent aggressive surgery were included in Group 1,and those who did not receive aggressive surgery were included in Group 2. <h3>Results</h3> The patients in Group 1 have received more cycles of chemotherapy (p=0.028).The study population’s median progression-free survival (PFS) was 11.8 months,the mean overall survival (OS) was 67.3 months.Median PFS was determined as 11.3 months for Group 1 and 12.2 months for Group 2.No statistically significant difference was observed between the two groups regarding median PFS(p=0,593).Mean OS was 46.2 months for Group 1 and 75.6 months for Group 2.The Mean OS of Group 2 was statistically significantly more extended than Group 1(p=0.011). <h3>Conclusion</h3> We aimed to analyze the effect of aggressive surgery on the survival outcomes of ovarian cancer patients.We did not observe a clear benefit of aggressive surgery since the PFS results were similar in the two groups of patients.The longer OS in Group 2 might result from subsequent treatments,including surgery,single-agent chemotherapy, and combined chemotherapy regimens.Although there was a limited number of patients in our study, this data will contribute to the literature. <h3>Disclosures</h3> None." @default.
- W4387136019 created "2023-09-29" @default.
- W4387136019 creator A5002428587 @default.
- W4387136019 creator A5010275447 @default.
- W4387136019 creator A5016180768 @default.
- W4387136019 creator A5024342842 @default.
- W4387136019 creator A5092960987 @default.
- W4387136019 date "2023-09-01" @default.
- W4387136019 modified "2023-10-18" @default.
- W4387136019 title "#129 Survival outcomes of the patients who underwent aggressive cytoreductive surgery for ovarian cancer" @default.
- W4387136019 doi "https://doi.org/10.1136/ijgc-2023-esgo.517" @default.
- W4387136019 hasPublicationYear "2023" @default.
- W4387136019 type Work @default.
- W4387136019 citedByCount "0" @default.
- W4387136019 crossrefType "proceedings-article" @default.
- W4387136019 hasAuthorship W4387136019A5002428587 @default.
- W4387136019 hasAuthorship W4387136019A5010275447 @default.
- W4387136019 hasAuthorship W4387136019A5016180768 @default.
- W4387136019 hasAuthorship W4387136019A5024342842 @default.
- W4387136019 hasAuthorship W4387136019A5092960987 @default.
- W4387136019 hasBestOaLocation W43871360191 @default.
- W4387136019 hasConcept C121608353 @default.
- W4387136019 hasConcept C126322002 @default.
- W4387136019 hasConcept C141071460 @default.
- W4387136019 hasConcept C167135981 @default.
- W4387136019 hasConcept C2776694085 @default.
- W4387136019 hasConcept C2777910003 @default.
- W4387136019 hasConcept C2780427987 @default.
- W4387136019 hasConcept C2780435969 @default.
- W4387136019 hasConcept C2780739268 @default.
- W4387136019 hasConcept C2781100745 @default.
- W4387136019 hasConcept C71924100 @default.
- W4387136019 hasConceptScore W4387136019C121608353 @default.
- W4387136019 hasConceptScore W4387136019C126322002 @default.
- W4387136019 hasConceptScore W4387136019C141071460 @default.
- W4387136019 hasConceptScore W4387136019C167135981 @default.
- W4387136019 hasConceptScore W4387136019C2776694085 @default.
- W4387136019 hasConceptScore W4387136019C2777910003 @default.
- W4387136019 hasConceptScore W4387136019C2780427987 @default.
- W4387136019 hasConceptScore W4387136019C2780435969 @default.
- W4387136019 hasConceptScore W4387136019C2780739268 @default.
- W4387136019 hasConceptScore W4387136019C2781100745 @default.
- W4387136019 hasConceptScore W4387136019C71924100 @default.
- W4387136019 hasLocation W43871360191 @default.
- W4387136019 hasOpenAccess W4387136019 @default.
- W4387136019 hasPrimaryLocation W43871360191 @default.
- W4387136019 hasRelatedWork W2014690672 @default.
- W4387136019 hasRelatedWork W2057286780 @default.
- W4387136019 hasRelatedWork W2065800215 @default.
- W4387136019 hasRelatedWork W2133480631 @default.
- W4387136019 hasRelatedWork W2581831974 @default.
- W4387136019 hasRelatedWork W2944256364 @default.
- W4387136019 hasRelatedWork W3097676887 @default.
- W4387136019 hasRelatedWork W4255034425 @default.
- W4387136019 hasRelatedWork W59268075 @default.
- W4387136019 hasRelatedWork W74951144 @default.
- W4387136019 isParatext "false" @default.
- W4387136019 isRetracted "false" @default.
- W4387136019 workType "article" @default.